Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The EURODIAB IDDM Complications Study involved the examination of 3250 randomly selected insulin-dependent diabetic patients, from 31 centres in 16 European countries. Part of the examination included an assessment of neurological function including neuropathic symptoms and physical signs, vibration perception threshold, tests of autonomic function and the prevalence of impotence. The prevalence of diabetic neuropathy across Europe was 28% with no significant geographical differences. Significant correlations were observed between the presence of diabetic peripheral neuropathy with age (p < 0.05), duration of diabetes (p < 0.001), quality of metabolic control (p < 0.001), height (p < 0.01), the presence of background or proliferative diabetic retinopathy (p < 0.01), cigarette smoking (p < 0.001), high-density lipoprotein cholesterol (p < 0.001) and the presence of cardiovascular disease (p < 0.05), thus confirming previous associations. New associations have been identified from this study - namely with elevated diastolic blood pressure (p < 0.05), the presence of severe ketoacidosis (p < 0.001), an increase in the levels of fasting triglyceride (p < 0.001), and the presence of microalbuminuria (p < 0.01). All the data were adjusted for age, duration of diabetes and HbA1c. Although alcohol intake correlated with absence of leg reflexes and autonomic dysfunction, there was no overall association of alcohol consumption and neuropathy. The reported problems of impotence were extremely variable between centres, suggesting many cultural and attitudinal differences in the collection of such information in different European countries. In conclusion, this study has identified previously known and new potential risk factors for the development of diabetic peripheral neuropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Furthermore, even in more contemporary cohorts with recent-onset T2D prevalence rates of up to 25% have been observed,545,546 including in youth417,612–615 or at different degrees of glucose intolerance.616”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [545]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Young, M. J., Boulton, A. J. M., Macleod, A. F., Williams, D. R. R., & Sonksen, P. H. (1993) · Diabetologia · doi:10.1007/bf00400697 · Cited by 1,502
Dyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D. M., O'Brien, P. C., & Melton, L. J. (1993) · Neurology · doi:10.1212/wnl.43.4.817 · Cited by 1,482
The Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in Diabetes
Ewing, D. J., Martyn, C. N., Young, R. J., & Clarke, B. F. (1985) · Diabetes Care · doi:10.2337/diacare.8.5.491 · Cited by 1,434 · cited 1×
“1) the presence of one or more symptoms; 2) absence of two or more ankle or knee reflexes; 3) vibration perception threshold which was abnormal relating to age-related measures [12] and 4) abnormal autonomic function assessed using Ewing’s definitons [13] of postural hypotension with a fall in systolic blood pressure…”
MethodPirart, J. (1978) · Diabetes Care · doi:10.2337/diacare.1.3.168 · Cited by 1,290
Maser, R. E., Steenkiste, A. R., Dorman, J. S., Nielsen, V. K., Bass, E. B., Manjoo, Q., Drash, A. L., Becker, D. J., Kuller, L. H., Greene, D. A., et al. (1989) · Diabetes · doi:10.2337/diab.38.11.1456 · Cited by 408
Pirart, J. (1978) · Diabetes Care · doi:10.2337/diacare.1.4.252 · Cited by 358
Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study
Stephenson, J., Fuller, J. H., & EUROBIAB IDDM Complications Study Group (1994) · Diabetologia · doi:10.1007/bf00398055 · Cited by 345
Self-citationReport and Recommendations of the San Antonio Conference on Diabetic Neuropathy
(1988) · Diabetes · doi:10.2337/diab.37.7.1000 · Cited by 308
Malik, R. A., Newrick, P. G., Sharma, A. K., Jennings, A., Ah-See, A. K., Mayhew, T. M., Jakubowski, J., Boulton, A. J. M., & Ward, J. D. (1989) · Diabetologia · doi:10.1007/bf00505180 · Cited by 294
Self-citationSENSORY NEUROPATHY IN NON-INSULIN-DEPENDENT DIABETES MELLITUS
FRANKLIN, G. M., KAHN, L. B., BAXTER, J., MARSHALL, J. A., & HAMMAN, R. F. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115547 · Cited by 281
Cited by
Items 101–200 of 693
Diabetic Neuropathy Differs in Type 1 and Type 2 Diabetes
Sima, A. A. F., & Kamiya, H. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1372.004 · Cited by 105
Entrapment neuropathies in diabetes mellitus
Rota, E., & Morelli, N. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i17.342 · Cited by 105
Pfannkuche, A., Alhajjar, A., Ming, A., Walter, I., Piehler, C., & Mertens, P. R. (2020) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2020.100053 · Cited by 112
Transcriptional Profiling of Diabetic Neuropathy in the BKS db/db Mouse
Pande, M., Hur, J., Hong, Y., Backus, C., Hayes, J. M., Oh, S. S., Kretzler, M., & Feldman, E. L. (2011) · Diabetes · doi:10.2337/db10-1541 · Cited by 104
“Dysregulation of lipid metabolism is implicated in peripheral neuropathy (7,30,33,49), but the mechanism of its effect is not well understood.”
BackgroundA Comprehensive Review of Erectile Dysfunction in Men with Diabetes
Kamenov, Z. A. (2014) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0034-1394383 · Cited by 137
“DN is the most common diabetic complication, affecting 10–90 % of people with diabetes, depending of the diagnostic criteria and the age and duration of DM (Vinik et al., 1992; Young et al., 1993; Dyck et al., 1993; Tesfaye et al., 1996).”
BackgroundKempler, P., Amarenco, G., Freeman, R., Frontoni, S., Horowitz, M., Stevens, M., Low, P., Pop‐Busui, R., Tahrani, A. A., Tesfaye, S., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1223 · Cited by 101
“In the EURODIAB IDDM Complications Study [22], 16% of patients (range: 2–35”
BackgroundSelf-citationAhmad, I., Noohu, M. M., Verma, S., Singla, D., & Hussain, M. E. (2019) · Gait & Posture · doi:10.1016/j.gaitpost.2019.08.018 · Cited by 113
Rudofsky, G., Reismann, P., Witte, S., Humpert, P. M., Isermann, B., Chavakis, T., Tafel, J., Nosikov, V. V., Hamann, A., Nawroth, P. P., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.179 · Cited by 104
Kızılay, F., Gali, H. E., & Şerefoğlu, E. C. (2016) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2016.07.002 · Cited by 106
“ev 2016;-:1e7 retinopathy,(4) and peripheral neuropathy.(5,6) DM causes these complications through vascular, neurogenic, and psychogenic pathways.”
BackgroundTesfaye, S. H., & Kempler, P. (2005) · Diabetologia · doi:10.1007/s00125-005-1721-7 · Cited by 113
Self-citationA Growing Troubling Triad: Diabetes, Aging, and Falls
Crews, R. T., Yalla, S. V., Fleischer, A. E., & Wu, S. (2013) · Journal of Aging Research · doi:10.1155/2013/342650 · Cited by 94
“[13] S.”
BackgroundWhither pathogenetic treatments for diabetic polyneuropathy?
Boulton, A. J. M., Kempler, P., Ametov, A., & Ziegler, D. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2397 · Cited by 89
Review of the role of cigarette smoking in diabetic foot
Xia, N., Morteza, A., Yang, F., Cao, H., & Wang, A. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12952 · Cited by 111
Mizokami-Stout, K. R., Li, Z., Foster, N. C., Shah, V., Aleppo, G., McGill, J. B., Pratley, R., Toschi, E., Ang, L., Pop-Busui, R., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1583 · Cited by 88
“Thenext interestingfinding is a slightly higher prevalence of DPN in women, irrespective of pain, which has not been found in other large cohorts with type 1 diabetes (8,16,18,24).”
BackgroundResultNeuropathy and neural plasticity in the subcutaneous white adipose depot
Blaszkiewicz, M., Willows, J. W., Dubois, A. L., Waible, S., DiBello, K., Lyons, L. L., Johnson, C. P., Paradie, E., Banks, N., Motyl, K., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0221766 · Cited by 87
Misra, S. L., Craig, J. P., Patel, D. V., McGhee, C. N. J., Pradhan, M. A., Ellyett, K. M., Kilfoyle, D., & Braatvedt, G. D. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16711 · Cited by 87
Pathogenesis of Painful Diabetic Neuropathy
Aslam, A., Singh, J., & Rajbhandari, S. M. (2014) · Pain Research and Treatment · doi:10.1155/2014/412041 · Cited by 108
“In the large, prospective EURODIAB study in 16 European countries, almost one-quarter of type 1 patients developed new onset painful diabetic neuropathy over a seven-year period [8].”
Beulens, J. W. J., Kruidhof, J. S., Grobbee, D. E., Chaturvedi, N., Fuller, J., & Soedamah‐Muthu, S. S. (2008) · Diabetologia · doi:10.1007/s00125-008-1091-z · Cited by 94
“[11], on the other hand, did not find an association, but detailed results of this analysis were not reported.”
BackgroundMethodResultInfluentialSelf-citationGlycated Hemoglobin (HbA1c) as a Biomarker for Diabetic Foot Peripheral Neuropathy
Casadei, G., Filippini, M., & Brognara, L. (2021) · Diseases · doi:10.3390/diseases9010016 · Cited by 112
Painful diabetic neuropathy: Diagnosis and management
Hartemann, A., Attal, N., Bouhassira, D., Dumont, I., Gin, H., Jeanne, S., Saïd, G., & Richard, J.-L. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2011.06.003 · Cited by 88
“[34] Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-”
BackgroundA Prospective Study of Predictors for Foot Ulceration in Type 2 Diabetes
Kästenbauer, T., Sauseng, S., Sokol, G., Auinger, M., & Irsigler, K. (2001) · Journal of the American Podiatric Medical Association · doi:10.7547/87507315-91-7-343 · Cited by 84
Genetic studies of human neuropathic pain conditions: a review
Zorina-Lichtenwalter, K., Parisien, M., & Diatchenko, L. B. (2017) · Pain · doi:10.1097/j.pain.0000000000001099 · Cited by 86
“Prolonged glycemic mismanagement and disruption of nerve microvasculature are the putative disease-associated risk factors.(136,137) However, given the incomplete penetrance of neuropathic pain in diabetic patients, the search for genetic contributors is ongoing.”
BackgroundIntegrated Tobacco Cessation Counseling in a Diabetes Self-management Training Program
Hokanson, J. M., Anderson, R. L., Hennrikus, D. J., Lando, H. A., & Kendall, D. M. (2006) · The Diabetes Educator · doi:10.1177/0145721706289914 · Cited by 81
Heesom, A. E., Millward, A., & Demaine, A. G. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.2.213 · Cited by 80
“Diabetic neuropathy is an extremely common complication in patients with insulin dependent diabetes mellitus (IDDM) with a prevalence of about 25%-30%.”
BackgroundSpectrum of Diabetic Neuropathy: New Insights in Diagnosis and Treatment
Dillon, B. R., Ang, L. P., & Pop‐Busui, R. (2024) · Annual Review of Medicine · doi:10.1146/annurev-med-043021-033114 · Cited by 105
Diabetic neuropathy in children and adolescents
Trotta, D., Verrotti, A., Salladini, C., & Chiarelli, F. (2004) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2004.00041.x · Cited by 87
The clinical use of the 10g monofilament and its limitations: A review
Tan, L. S. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.06.021 · Cited by 79
The distinctive role of menthol in pain and analgesia: Mechanisms, practices, and advances
Li, Z., Zhang, H., Wang, Y., Li, Y., Li, Q., & Zhang, L. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1006908 · Cited by 93
Li, L., Chen, J., Wang, J., & Cai, D.-H. (2014) · Primary care diabetes · doi:10.1016/j.pcd.2014.07.006 · Cited by 76
Rahman, M., Griffin, S. J., Rathmann, W., & Wareham, N. J. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00931.x · Cited by 73
Nangle, M. R., Cotter, M. A., & Cameron, N. E. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2396 · Cited by 76
Explanations for the Lower Rates of Diabetic Neuropathy in Indian Asians Versus Europeans
Abbott, C. A., Chaturvedi, N., Malik, R. A., Salgami, E., Yates, A. P., Pemberton, P. W., & Boulton, A. J. M. (2010) · Diabetes Care · doi:10.2337/dc09-2067 · Cited by 69
“Height is often cited as a key risk factor for neuropathy; it is therefore not surprising that the shorter height of Indian Asians contributes to their lower risk (18).”
Association between diabetic foot ulcer and diabetic retinopathy
Hwang, D. D.-J., Lee, K. M., Park, M. S., Choi, S. H., Park, J. I., Cho, J. H., Park, K. H., & Woo, S. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175270 · Cited by 81
Crook, M. A., Pickup, J. C., Lumb, P. J., Georgino, F., Webb, D. J., Fuller, J., & The EURODIAB IDDM Complications Study Group (2001) · Diabetes Care · doi:10.2337/diacare.24.2.316 · Cited by 71
Self-citationCai, Z., Yang, Y., & Zhang, J. (2021) · Scientific Reports · doi:10.1038/s41598-020-79276-0 · Cited by 86
Burning through the pain: treatments for diabetic neuropathy
Javed, S., Alam, U., & Malik, R. A. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12535 · Cited by 78
“Data from the EURODIAB study [22] in type 1 Diabetes found that inadequate glycaemic control was associated with the development of DPN in a cohort of 3000 patients.”
MethodPeripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors
Janghorbani, M., Rezvanian, H., Kachoei, A., Ghorbani, A., Chitsaz, A., Izadi, F., & Amini, M. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00716.x · Cited by 70
“The association observed in age-adjusted analyses between PN and the presence of IHD and any retinopathy has also been described previously (15, 23, 27).”
BackgroundResultInfluentialNeurovascular disease, antioxidants and glycation in diabetes
Dickinson, P. J., Carrington, A. L., Frost, G. S., & Boulton, A. J. M. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.305 · Cited by 70
Diabetic neuropathy in Mauritius: prevalence and risk factors
Shaw, J. E., Hodge, A. M., de Courten, M., Dowse, G. K., Gareeboo, H., Tuomilehto, J., Alberti, K. G. M. M., & Zimmet, P. (1998) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(98)00100-4 · Cited by 70
Bondar, A., Popa, A. R., Παπάνας, Ν., Popoviciu, M. S., Vesa, C. M., Sabau, M., Daina, C. M., Stoica, R. A., Katsiki, N., & Stoian, A. P. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10122 · Cited by 92
“There are other factors involved in DN development, including obesity, metabolic syndrome, insulin resistance, alcohol consumption, platelet activation and increased aggregability, low vitamin D, subclinical inflammation (25,26), a paraneoplastic syndrome in different cancers (27‐29), associated chemotherapy treatment…”
BackgroundPeripheral Insensate Neuropathy—A Tall Problem for US Adults?
Cheng, Y. J., Gregg, E. W., Kahn, H. S., Williams, D. E., De Rekeneire, N., & Narayan, K. M. V. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj281 · Cited by 68
“Factors associated with neuropathy include diabetes mellitus, poor glycemic control, male sex, White race, and older age (1, 7, 8).”
BackgroundResultRecent advances in the diagnosis and management of diabetic neuropathy
Rathur, H. M., & Boulton, A. J. M. (2005) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.87b12.16710 · Cited by 69
High HDL cholesterol: A risk factor for diabetic retinopathy? Findings from NO BLIND study
Sasso, F. C., Pafundi, P. C., Gelso, A., Bono, V., Costagliola, C., Marfella, R., Sardu, C., Rinaldi, L., Galiero, R., Acierno, C., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.03.028 · Cited by 70
Peripheral Neuropathy: A Review
Mauermann, M. L., & Staff, N. P. (2025) · JAMA · doi:10.1001/jama.2025.19400 · Cited by 95
Diabetic Neuropathies: Unanswered Questions
Harati, Y. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.01.002 · Cited by 68
Exercise as Therapy for Diabetic and Prediabetic Neuropathy
Singleton, J. R., Smith, A. G., & Marcus, R. L. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0682-6 · Cited by 75
Llewelyn, J., Tomlinson, D. R., & Thomas, P. K. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-9491-7.50088-0 · Cited by 77
Electrophysiological findings of peripheral neuropathy in newly diagnosed type II diabetes mellitus
Rota, E., Quadri, R., Fanti, E., Isoardo, G., Poglio, F., Tavella, A., Paolasso, I., Ciaramitaro, P., Bergamasco, B., & Cocito, D. (2005) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2005.00046.x · Cited by 67
“This remarkable discrepancy is partially because of the differences in methods (sets of electrophysiological and clinical criteria adopted) and demographic data (Tesfaye et al., 1996).”
ResultTkac, I., & Bril, V. (1998) · Diabetes Care · doi:10.2337/diacare.21.10.1749 · Cited by 66
Garg, S. S., Dubey, R., Sharma, S., Vyas, A., & Gupta, J. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125636 · Cited by 67
Jose, V. M., Bhansali, A., Hota, D., & Pandhi, P. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02093.x · Cited by 66
Glycemic Control Is Related to the Morphological Severity of Diabetic Sensorimotor Polyneuropathy
Perkins, B. A., Greene, D. A., & Bril, V. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.748 · Cited by 66
“Duration of diabetes, which was reported to be a risk factor for the presence of DSP (1,2,5,10), was shown in the present study to be related to the morphological severity of DSP.”
BackgroundThe Eurodiab study: What has this taught us about diabetic peripheral neuropathy?
Tesfaye, S. H., & Selvarajah, D. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0070-1 · Cited by 67
“The assessment of neuropathy included 1) evaluation of neuropathic symptoms; 2) scored clinical examination; 3) measurement of vibration perception threshold; and 4) autonomic function tests by measuring two cardiovascular refl ex responses [ 14 ].”
BackgroundMethodResultSelf-citationTargeting glucose metabolism for healthy aging
Brewer, R. A., Gibbs, V. K., & Smith, D. L. (2016) · Nutrition and Healthy Aging · doi:10.3233/nha-160007 · Cited by 68
“[22] Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, Nuber A, Pozza G, Ward JD.”
BackgroundContribution of genetic and environmental effects to postural balance in older female twins
Pajala, S., Era, P. A., Koskenvuo, M. J., Kaprio, J. A., Tolvanen, A. J., Heikkinen, E. M., Tiainen, K., & Rantanen, T. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00660.2003 · Cited by 82
Subclinical diabetic neuropathy. A common complication in Saudi diabetics
Akbar, D. H., Mira, S. A., Zawawi, T. H., & Malibary, H. M. (2000) · Saudi Medical Journal · doi:10.15537/1658-3175.1168 · Cited by 64
Sexual dysfunction in diabetes
Várkonyi, T. T., & Kempler, P. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00017-5 · Cited by 66
Idzior−Waluś, B., Mattock, M. B., Solnica, B., Stevens, L. K., Fuller, J., & the EURODIAB IDDM Complications Study Group (2001) · Diabetic Medicine · doi:10.1046/j.0742-3071.2001.00571.x · Cited by 69
Self-citationMalik, R. A., Aldinc, E., Chan, S.-P., Deerochanawong, C., Hwu, C., Rosales, R. L., Yeung, C., Fujii, K., & Parsons, B. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0536-5 · Cited by 62
Rauck, R., Makumi, C. W., Schwartz, S., Graff, O., Meno‐Tetang, G., Bell, C. F., Kavanagh, S. T., & McClung, C. L. (2013) · Pain Practice · doi:10.1111/papr.12014 · Cited by 61
“Any event 79 (66) 45 (73) 38 (68) 86 (74) 47 (71) Dizziness 7 (6) 9 (15) 8 (14) 16 (14) 9 (14) Somnolence 5 (4) 2 (3) 7 (13) 14 (12) 9 (14) Nausea 9 (8) 7 (11) 4 (7) 7 (6) 3 (5) Peripheral edema 5 (4) 2 (3) 0 11 (9) 11 (17) Headache 9 (8) 3 (5) 4 (7) 4 (3) 6 (9) Muscle spasms 4 (3) 6 (10) 0 11 (9) 3 (5) Diarrhea 6 (5)…”
The Epidemiology of Diabetic Neuropathy
Boyko, E. J. (1998) · Humana Press eBooks · doi:10.1007/978-1-4612-1816-6_1 · Cited by 61
Allen, M. D., Kimpinski, K., Doherty, T. J., & Rice, C. L. (2013) · Clinical Neurophysiology · doi:10.1016/j.clinph.2013.09.037 · Cited by 69
“…this nervous system dysfunction may be due to a combination of various metabolic and vascular factors (see Zochodne, 2007 for review), and is correlated with disease duration and quality of serum glucose control (e.g. as indicated by HbA1c levels) (Tesfaye et al., 1996; Bril et al., 1996).”
BackgroundMicrovascular disease in children and adolescents with type 1 diabetes and obesity
Marcovecchio, M. L., & Chiarelli, F. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1624-9 · Cited by 70
Gruden, G., Giunti, S., Barutta, F., Chaturvedi, N., Witte, D. R., Tricarico, M., Fuller, J. H., Cavallo Perin, P., & Bruno, G. (2012) · Diabetes Care · doi:10.2337/dc11-1739 · Cited by 61
“04 or postural hypotension with a decrease in systolic blood pressure of $20 mmHg (10,11).”
BackgroundSelf-citationSurgical aspects of the diabetic foot
Robinson, A. H. N., Pasapula, C., & Brodsky, J. W. (2008) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.91b1.21196 · Cited by 63
Buyken, A. E., Toeller, M., Heitkamp, G., Vitelli, F., Stehle, P., Scherbaum, W. A., & Fuller, J. (1998) · Diabetologia · doi:10.1007/s001250051003 · Cited by 65
Self-citationNeuronal Ca2+ disregulation in diabetes mellitus
Biessels, G. J., ter Laak-Poort, M., Hamers, F. P. T., & Gispen, W. H. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01844-7 · Cited by 68
C-peptide and diabetic neuropathy
Sima, A. A. F. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.9.1471 · Cited by 63
“The prevalence of DPN varies from 10% within 1 year of diagnosis to 50% in patients with diabetes for 25 years or longer [5-7] and with an average prevalence of 30% [8].”
BackgroundThe potential role of cell adhesion molecules in the pathogenesis of diabetic neuropathy
Jude, E. B., Abbott, C. A., Young, M. J., Anderson, S. G., Douglas, J. T., & Boulton, A. J. M. (1998) · Diabetologia · doi:10.1007/s001250050911 · Cited by 60
Jeyam, A., McGurnaghan, S. J., Blackbourn, L. A. K., McKnight, J. M., Green, F., Collier, A., McKeigue, P. M., & Colhoun, H. M. (2020) · Diabetes Care · doi:10.2337/dc19-1582 · Cited by 59
“The data reinforce previous findings (26) and give support to the idea of a holistic, comprehensive approach to diabetes management.”
BackgroundResultInfluentialBasu, P., Maier, C. G.-A., & Basu, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094666 · Cited by 68
Prevalence of Q-T Interval Dispersion in Type 1 Diabetes and Its Relation With Cardiac Ischemia
Veglio, M., Giunti, S., Stevens, L. K., Fuller, J., Perin, P. C., & The EURODIAB IDDM Complications Study Group (2002) · Diabetes Care · doi:10.2337/diacare.25.4.702 · Cited by 76
Self-citationAbougalambou, S. S. I., & Abougalambou, A. S. (2014) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2014.04.019 · Cited by 59
Bosi, P. L., Carvalho, A. M., Contrera, D., Casale, G., Pereira, M. A., Gronner, M. F., Diogo, T. M., Torquarto, M. T. D. C. G., Oishi, J., & Leal, A. M. O. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000600006 · Cited by 132
Advances in diabetes for the millennium: new treatments for diabetic neuropathies.
Vinik, A. I. (2004) · PubMed · Cited by 58
The Management of Diabetic Neuropathy in CKD
Pop‐Busui, R., Roberts, L., Pennathur, S., Kretzler, M., Brosius, F. C., & Feldman, E. L. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.10.050 · Cited by 64
Kästenbauer, T., Irsigler, P., Sauseng, S., Grimm, A., & Prager, R. (2004) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(03)00071-0 · Cited by 58
Update on the Management of Diabetic Neuropathy
Ang, L., Cowdin, N., Mizokami-Stout, K., & Pop-Busui, R. (2018) · Diabetes Spectrum · doi:10.2337/ds18-0036 · Cited by 55
“Contemporary prevalence rates for DSPN remain high, occurring in at least 20% of people with type 1 diabetes of >20 years’ duration (1,6,7), 10–15% of people with newly diagnosed type 2 diabetes (1,8,9), and 10–30% of subjects with impaired glucose tolerance (IGT) or metabolic syndrome (1,3,4).”
BackgroundGewandter, J. S., Kleckner, A. S., Marshall, J. H., Brown, J. S., Curtis, L. H., Bautista, J., Dworkin, R. H., Kleckner, I. R., Kolb, N., Mohile, S. G., et al. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-05063-x · Cited by 62
Aleidan, F. A. S., Ahmed, B. A., Alotaibi, F., Aleesa, D. H., Al-Hefdhi, N., Badri, M., & Gader, A. G. A. (2020) · International Journal of General Medicine · doi:10.2147/ijgm.s273807 · Cited by 56
The conundrum of diabetic neuropathies—Past, present, and future
Ang, L. P., Mizokami‐Stout, K., Eid, S., Elafros, M. A., Callaghan, B. C., Feldman, E. L., & Pop‐Busui, R. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108334 · Cited by 66
Charles, M., Soedamah‐Muthu, S. S., Tesfaye, S. H., Fuller, J., Arezzo, J. C., Chaturvedi, N., Witte, D. R., & EURODIAB Prospective Complications Study Investigators (2010) · Diabetes Care · doi:10.2337/dc10-0456 · Cited by 61
“Proliferative retinopathy 305 (20) 47 (12)”
BackgroundSelf-citationDuBrava, S., Mardekian, J., Sadosky, A., Bienen, E. J., Parsons, B., Hopps, M., & Markman, J. (2017) · Pain Medicine · doi:10.1093/pm/pnw096 · Cited by 53
Estimated prevalence of peripheral neuropathy and associated pain in adults with diabetes in France
Wu, E. Q., Borton, J., Saïd, G., Le, T. K., Monz, B. U., Rosilio, M., & Avoinet, S. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x210516 · Cited by 53
“Notes: [1] Data are based on self-reported survey responses to MNSI [2] Each MNSI question has been rephrased as a symptom for presentation in this table [3] The symptoms Muscle cramps in legs and/or feet and Weak all over most of the time were not used in calculating the DPN score [4] DPN was defined as having an MNS…”
MethodScoring systems to screen for diabetic peripheral neuropathy
Yang, Z., Chen, R., Zhang, Y., Huang, Y., Hong, T., Sun, F., Ji, L., & Zhan, S. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010974 · Cited by 61
RetractedResource use among patients with diabetes, diabetic neuropathy, or diabetes with depression
Le, T. K., Able, S. L., & Lage, M. J. (2006) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-4-18 · Cited by 52
“Approximately 10% of patients have neuropathy at the time of diabetes diagnosis [10,11], and that number increases to as much as 50% among patients who have had diabetes for 15 or more years [10,12].”
Cameron, N. E., Cotter, M. A., Inkster, M. E., & Nangle, M. R. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00123-2 · Cited by 53
Incidence and Risk Factors of Prolonged QTc Interval in Type 1 Diabetes
Giunti, S., Bruno, G., Lillaz, E., Gruden, G., Lolli, V. E., Chaturvedi, N., Fuller, J., Veglio, M., Cavallo‐Perin, P., & The EURODIAB IDDM Complications Study Group (2007) · Diabetes Care · doi:10.2337/dc07-0063 · Cited by 50
“04 and/or postural hypotension with a fall in systolic blood pressure 20 mmHg (15).”
BackgroundSelf-citationPrevalence and characteristics of diabetic polyneuropathy in Passo Fundo, South of Brazil
Tres, G. S., Lisboa, H. R. K., de Syllos, R. W. C., Canani, L. H. S., & Gross, J. L. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000600014 · Cited by 51
“Almost half of patients with microalbuminuria had neuropathy (18,19).”
BackgroundEarlier development of diabetic neuropathy in men than in women with type 2 diabetes mellitus
Kamenov, Z. A., Parapunova, R., & Georgieva, R. (2010) · Gender Medicine · doi:10.1016/j.genm.2010.11.001 · Cited by 53
Nonproliferative Diabetic Retinopathy and Diabetic Macular Edema
Wiley, H. E., & Ferris, F. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00047-3 · Cited by 63
The prevalence of diabetic peripheral neuropathy and related factors.
Tabatabaei‐Malazy, O., Mohajeri-Tehrani, M., Madani, S. H., Heshmat, R., & Larijani, B. A. (2011) · PubMed Central · Cited by 49
Blood–Nerve Barrier (BNB) Pathology in Diabetic Peripheral Neuropathy and In Vitro Human BNB Model
Takeshita, Y., Sato, R., & Kanda, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010062 · Cited by 52
“Recent epidemiological studies on DPN in patients with type 1 and type 2 diabetes mellitus have indicated coronary vascular risk factors, such as obesity, dyslipidemia, hypertension, and smoking, might be also involved in the onset of DPN, especially in type 2 diabetes mellitus [63,64].”
BackgroundType 1 Diabetic Neuropathy and C‐peptide
Sima, A. A. F., Zhang, W., & Grunberger, G. (2003) · Journal of Diabetes Research · doi:10.1080/15438600490424541 · Cited by 51
“The prevalence of DPN varies from 10% within a year of diagnosis to 50% in patients with diabetes for 25 years or longer (Pirart, 1977; Vinik et al., 1992; Sima, 1994), and with an average prevalence of 30% (Tesfaye et al., 1996).”
BackgroundSmoking, Diabetes and Hyperlipidaemia
Mikhailidis, D. P., Papadakis, J. A., & Ganotakis, E. S. (1998) · Journal of the Royal Society of Health · doi:10.1177/146642409811800209 · Cited by 48
Type 1 diabetes and celiac disease in adults: glycemic control and diabetic complications
Bakker, S. F., Tushuizen, M. E., von Blomberg, M. E., Mulder, C. J. J., & Şimşek, S. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0395-0 · Cited by 52
“thy, nephropathy, and neuropathy in T1DM patients [3–5].”
BackgroundDehghani, C., Pritchard, N., Edwards, K. P., Russell, A. W., Malik, R. A., & Efron, N. (2016) · Cornea · doi:10.1097/ico.0000000000000760 · Cited by 47
Pathways in the Diagnosis and Management of Diabetic Polyneuropathy
Kaku, M. C., Vinik, A. I., & Simpson, D. M. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0609-2 · Cited by 52
Changing Perspectives in Diabetic Foot Ulcer Management
Dang, C. N., & Boulton, A. J. M. (2003) · The International Journal of Lower Extremity Wounds · doi:10.1177/1534734603002001002 · Cited by 46
Strokov, I. A., Bursa, T. R., Дрепа, О. И., Zotova, E., Nosikov, V. V., & As, A. (2003) · Acta Diabetologica · doi:10.1007/s00592-003-0123-x · Cited by 46
Metadata
- Authors
- Tesfaye, S., Stevens, L. K., Stephenson, J. M., Fuller, J. H., Plater, M., Ionescu-Tirgoviste, C., Nuber, A., Pozza, G., & Ward, J. D.
- Affiliations
- Royal Liverpool University Hospital (GB)
- University College London (GB)
- Royal Hallamshire Hospital (GB)
- München Klinik Schwabing (DE)
- IRCCS Ospedale San Raffaele (IT)
- Venue
- Diabetologia
- Published
- 1996-10-23
- Volume
- 39
- Issue
- 11
- Pages
- 1377-1384
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2049568996
- Cited by
- 695
- References
- 30
- Citations by year
- 2026: 7 · 2025: 20 · 2024: 17 · 2023: 30 · 2022: 27 · 2021: 34 · 2020: 32 · 2019: 30 · 2018: 35 · 2017: 23 · 2016: 27 · 2015: 36 · 2014: 41 · 2013: 36 · 2012: 27
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Pfizer
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- diabetic peripheral neuropathy, prevalence, type 1 diabetes, glycemic control, risk factors, diabetes duration, diabetic retinopathy, smoking, HDL cholesterol, cardiovascular disease, diastolic blood pressure, ketoacidosis, fasting triglycerides, microalbuminuria, autonomic dysfunction, erectile dysfunction, alcohol consumption
- MeSH terms
- Adolescent, Adult, Blood Pressure, Body Constitution, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetic Neuropathies, Diabetic Retinopathy, Europe, Female, Humans, Hypoglycemia, Lipids, Male, Middle Aged, Peripheral Nervous System Diseases, Regression Analysis, Risk Factors, Smoking, Body Mass Index, Prevalence, Diabetic Ketoacidosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.